Alzheimer's drug shows long-term benefits in behavior and cognition. EU approval of Blarcamesine could boost its market value ...

The only actual available "test" for Alzheimer’s disease in younger people would be to check someone's APOE 4 levels, which ...

In a statement posted by the Massachusetts Institute of Technology Monday, researchers said they have used data about fruit ...

The FDA said the results of the newly cleared blood test must be assessed in conjunction with other clinical information from ...

The test has a complicated name: The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio. But the goal of the test, created by ...

By combining information from many large datasets, MIT researchers have identified several new potential targets for treating or preventing Alzheimer's disease.

New research has linked the ... Researchers Find That Increase of 'CLU' Protein Promotes Brain Resilience and Could Provide Protection from Alzheimer's Disease Apr. 30, 2025 — Recently approved ...

New research has linked the ... Researchers Find That Increase of 'CLU' Protein Promotes Brain Resilience and Could Provide Protection from Alzheimer's Disease Apr. 30, 2025 — Recently approved ...

Study co-author Riccardo Calandrelli, a research associate within Professor Sheng Zhong's team, cautioned: "Anyone looking to recommend or take serine to mitigate Alzheimer's symptoms should ...

Join Dementia Research - find participants for your research studies and trials quickly and easily through this National Institute of Health Research platform.